Vertex, Inc.'s Q4 2024: Contradictory Insights on AI Investments, Pipeline Health, and Margin Expectations
Generated by AI AgentAinvest Earnings Call Digest
Thursday, Feb 27, 2025 12:45 pm ET1min read
VERX--
These are the key contradictions discussed in Vertex, Inc.'s latest 2024Q4 earnings call, specifically including: AI Investments, Pipeline Management, Gross Margin Expectations, Ecosio's Contribution and Integration, and Free Cash Flow Conversion Expectations:
Revenue and Earnings Growth:
- Vertex Inc. reported revenue of $178.5 million for Q4 2024, up 15.2% year-over-year, and adjusted EBITDA of $38.1 million, up 21.3%.
- The growth was driven by investments in e-invoicing, delayed expenses, and strong performance in cloud and ERP migrations.
Cloud Revenue and Strategic Focus:
- Cloud revenue increased by 27% year-over-year for Q4, with total cloud revenue exceeding on-premise revenue for the first time.
- This shift aligns with Vertex's strategic intent to focus on cloud solutions and is supported by the ongoing migrations to Oracle and SAP cloud platforms.
ARR and Customer Growth:
- Annual recurring revenue (ARR) grew nearly 18% to $603.1 million.
- The increase was driven by new business wins, such as a comprehensive seven-figure deal with a leading AI research company, and stable customer retention.
NRR and Cross-Sell Opportunities:
- Net revenue retention (NRR) was 109%, slightly lower than the previous year due to a strong comparable period.
- Although NRR was below expectations, the increase in new logo revenue and focus on cross-sell opportunities suggest that customer appetite for more products remains strong.
Revenue and Earnings Growth:
- Vertex Inc. reported revenue of $178.5 million for Q4 2024, up 15.2% year-over-year, and adjusted EBITDA of $38.1 million, up 21.3%.
- The growth was driven by investments in e-invoicing, delayed expenses, and strong performance in cloud and ERP migrations.
Cloud Revenue and Strategic Focus:
- Cloud revenue increased by 27% year-over-year for Q4, with total cloud revenue exceeding on-premise revenue for the first time.
- This shift aligns with Vertex's strategic intent to focus on cloud solutions and is supported by the ongoing migrations to Oracle and SAP cloud platforms.
ARR and Customer Growth:
- Annual recurring revenue (ARR) grew nearly 18% to $603.1 million.
- The increase was driven by new business wins, such as a comprehensive seven-figure deal with a leading AI research company, and stable customer retention.
NRR and Cross-Sell Opportunities:
- Net revenue retention (NRR) was 109%, slightly lower than the previous year due to a strong comparable period.
- Although NRR was below expectations, the increase in new logo revenue and focus on cross-sell opportunities suggest that customer appetite for more products remains strong.
Discover what executives don't want to reveal in conference calls
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet